0001209191-11-023116.txt : 20110418 0001209191-11-023116.hdr.sgml : 20110418 20110418123038 ACCESSION NUMBER: 0001209191-11-023116 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101001 FILED AS OF DATE: 20110418 DATE AS OF CHANGE: 20110418 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lindell Jody S CENTRAL INDEX KEY: 0001356151 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19756 FILM NUMBER: 11764945 MAIL ADDRESS: STREET 1: 2536 FILLMORE ST. CITY: SAN FRANCISCO STATE: CA ZIP: 94115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDL BIOPHARMA, INC. CENTRAL INDEX KEY: 0000882104 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943023969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 BUSINESS PHONE: 775-832-8500 MAIL ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 FORMER COMPANY: FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE DATE OF NAME CHANGE: 19930328 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2010-10-01 0 0000882104 PDL BIOPHARMA, INC. PDLI 0001356151 Lindell Jody S C/O PDL BIOPHARMA, INC. 932 SOUTHWOOD BOULEVARD INCLINE VILLAGE NV 89451 1 0 0 0 Common Stock 2010-10-01 4 P 0 285 5.2614 A 20168 D Common Stock 2011-03-15 4 P 0 89 5.5291 A 20257 D These shares were acquired pursuant to an automatic dividend reinvestment feature managed by the reporting person's investment advisor. /s/Christopher Stone, Attorney-in-Fact for Jody S. Lindell 2011-04-18